Difference between revisions of "Pentamidine (Nebupent)"
m |
|||
| Line 14: | Line 14: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | [[Category:Antifungals]] | ||
| + | [[Category:PCP prophylaxis]] | ||
| + | |||
| + | [[Category:Drugs FDA approved in 1989]] | ||
Revision as of 22:08, 27 October 2014
General information
Class/mechanism: Antifungal, known to have activity against Pneumocystis jiroveci. Mechanism not fully understood, but mechanism hypothesized to involve inhibition of DNA, RNA, phospholipid, and protein synthesis.[1][2]
Route: inhaled, IM, IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
Also known as
Benambax, Lomidine, Nebupent, Pentam, Pentam 300, Pentamidina Combino, Pentamidina Combinopharm, Pentamidina Filaxis, Pentamidina Richet, Pentamidine Dimesilate, Pentamidine Isethi, Pentamidine Isethionate, Pneumopent